Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice.
The ecological impact of roxithromycin given orally at 300 mg/day on the intestinal floras in six human volunteers was studied. The resulting fecal concentrations of active roxithromycin were in the range of 100 to 200 micrograms/g of feces. Consecutive modifications in the composition of the fecal floras were limited to a decrease in counts of total members of the family Enterobacteriaceae. The rest of the intestinal floras, including the predominant anaerobic floras, changed little. No overgrowth of Pseudomonas aeruginosa, staphylococci, fungi, or highly erythromycin-resistant strains of the family Enterobacteriaceae was observed. The strains of Enterobacteriaceae and of anaerobes isolated during treatment were not markedly more resistant to roxithromycin than those isolated before treatment started. Changes in intestinal resistance to colonization by exogenous microorganisms in gnotobiotic mice inoculated with human fecal flora were studied and were also found to be minimal. The impact of oral roxithromycin on the intestinal microbiota appears to be weaker than that previously observed with oral erythromycin, perhaps because the concentrations of roxithromycin in the feces were lower than those previously found for erythromycin.
Pecquet
S
S
Laboratoire d'Ecologie Microbienne, Institut Gustave-Roussy, Villejuif, France.
Chachaty
E
E
Tancrède
C
C
Andremont
A
A
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D001419:Bacteria / Q000187:drug effects* / Q000254:growth & development; D015169:Colony Count, Microbial; D005243:Feces / Q000382:microbiology*; D005856:Germ-Free Life; D006801:Humans; D007422:Intestines / Q000187:drug effects* / Q000382:microbiology; D051379:Mice; D008809:Mice, Inbred C3H; D008826:Microbial Sensitivity Tests; D015575:Roxithromycin / Q000097:blood / Q000494:pharmacology*
D015575:Roxithromycin